$GTCH According to Danny Rittman, CTO of GBT Technologies Inc. (OTC Pink: GTCH), the company elected to release the first version of its AI-powered human vitals device, qTerm with only three of the four originally-planned features included. He explained that this was a decision made to meet the demand brought on by the COVID-19 pandemic.

"Originally, the qTerm device was planned to come out in its first release with four features - body temperature, heart rate, blood pressure and oxygen," he said. "Due to the pandemic, we wanted to push it out faster [to get] something to the market to help with the [COVID-19] virus."

https://www.marketscreener.com/quote/stock/GB...-31707571/